一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Laronidase [usan:inn]

Laronidase [usan:inn] Struktur
210589-09-6
CAS-Nr.
210589-09-6
Englisch Name:
Laronidase [usan:inn]
Synonyma:
Laronidase;Aldurazyme;IDUA;Ec 3.2.1.76;alpha-L-Iduronidase;Laronidase [usan:inn];Human recombinant alpha-L-iduronidase;Iduronidase, alpha-L-(8-histidine) (human);ANTI-IDUA (CENTER) antibody produced in rabbit
CBNumber:
CB52495861
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Laronidase [usan:inn] Eigenschaften

storage temp. 
-20°C

Sicherheit

Laronidase [usan:inn] Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Mucopolysaccharidosis I (MPS I) is a rare genetic lysosomal storage disease caused by the deficiency of a-L-iduronidase, an enzyme required for the catabolism of dermatan sulfate and heparin sulfate. The deficiency blocks the degradation of these mucopolysaccharides, which accumulate in a variety of tissues including liver, spleen, heart and connective tissues. The clinical manifestations of MPS I can include progressive developmental delay, airways obstruction, hepatosplenomegaly, severe joint restriction and cardiovascular disease. There are three subtypes of MPS I depending on its clinical severity: Hurler’s syndrome (severe), Hurler-Scheie syndrome (moderate), and Scheie syndrome (mild). Among the existing therapies, bone marrow transplantation has been the only effective option for Hurler’s syndrome. Laronidase was launched as an enzyme replacement therapy for the treatment of patients with Hurler and Hurler-Scheie syndromes and patients with the Scheie syndrome who have moderate to severe symptoms. It is a recombinant form of the human a-L-iduronidase produced by overexpression in a Chinese hamster ovary cell line. The recommended dosage regimen of laronidase is 0.58 mg/kg of body weight administered once weekly as an intravenous infusion. The efficacy of laronidase was demonstrated in a 26-week, double-blind, placebo-controlled clinical trial by measuring improvement in pulmonary function and endurance. The laronidase-treated patients showed a mean increase of 4.0% in predicted forced vital capacity (FVC) and a mean increase of 38.0 m in the distance walked in 6 min as compared with placebo-treated patients. Reductions in liver size and in urinary glycosaminoglycan excretion were also observed. The most common adverse events associated with laronidase were upper respiratory tract infection, rash and injection site reaction.

Verwenden

Enzyme replacement in Mucopolysaccharidosis I (MPS I).

Laronidase [usan:inn] Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Laronidase [usan:inn] Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12323 58
Shanghai Yaji Biological Technology Co., Ltd. 021-34661275 15301693058
yajikit@163.com China 9935 58
Biolab Reagents 027-65279366 18108604356
products@biolabreagent.com China 9864 58
Tanmo Quality Inspection Technology Co., Ltd. --
23419001name@qq.com CHINA 6019 58
Signalway Antibody LLC --
info@sabbiotech.com China 6243 58
Beijing Biosynthesis Biotechnology Co Ltd --
sales@bioss.com.cn China 6102 58
Shanghai Yubo Biotechnology Co., Ltd 021-60514606 18321282235
sale1@shybsw.net China 8165 58
Shanghai Zhenke Biotechnology Co., Ltd 17317792356
3022304776@qq.com China 7276 58
Guangzhou Canyi Trading Co., Ltd. --
CHINA 2026 58
Guangzhou Serafin Biotechnology Co., Ltd --
CHINA 6583 58

  • alpha-L-Iduronidase
  • Ec 3.2.1.76
  • Human recombinant alpha-L-iduronidase
  • Iduronidase, alpha-L-(8-histidine) (human)
  • Laronidase [usan:inn]
  • ANTI-IDUA (CENTER) antibody produced in rabbit
  • IDUA
  • Aldurazyme
  • Laronidase
  • 210589-09-6
Copyright 2019 ? ChemicalBook. All rights reserved
滦南县| 铜川市| 广南县| 翼城县| 和平县| 遵化市| 类乌齐县| 新丰县| 喀喇| 顺平县| 册亨县| 辛集市| 井冈山市| 灵寿县| 曲靖市| 仙桃市| 辽源市| 合山市| 肥乡县| 布尔津县| 瑞昌市| 浦江县| 东山县| 修水县| 枣庄市| 定州市| 青海省| 龙门县| 尚志市| 茶陵县| 邢台县| 娄烦县| 大同县| 庐江县| 长治市| 东辽县| 吐鲁番市| 容城县| 道真| 县级市| 合阳县|